Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OnabotulinumtoxinA X for Forehead Lines
NCT05152576Phase 2Completed
- Sponsor
- Allergan
- Start
- Nov 2021
- Primary completion
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of onabotulinumtoxinA, sponsored by Allergan. Started Nov 2021; status: completed.
02
Drugs
onabotulinumtoxinA
Beyond the preview
Go deeper on NCT05152576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05152576.